PrEP Demographics and Disparity: The Race, Ethnicity, Gender Identity, Sex Assigned at Birth, Sexual Orientation and Age of Current PrEP Use

References

• Braksmajer, A., Fedor, T. M., Chen, S.-R., Corales, R., Holt, S., Valenti, W., & McMahon, J. M. (2018). Willingness to take PrEP for HIV prevention: The combined effects of race/ethnicity and provider trust. AIDS Education & Prevention, 30(1), 1–12. https://dx.doi.org/10.1521/aeap.2018.30.1.1
   PubMed Web of Science ®Google Scholar
• Buchbinder, S. P., Glidden, D. V., Liu, A. Y., McMahan, V., Guanira, J. V., Mayer, K. H., Grant, R. M., & Grant, R. M. (2014). HIV pre-exposure prophylaxis in men who have sex with men and transgender women: A secondary analysis of a phase 3 randomized controlled efficacy trial. Lancet Infectious Diseases, 14(6), 468–475. https://dx.doi.org/10.1016/S1473-3099(14)70025-8
   PubMed Web of Science ®Google Scholar
• Calabrese, S. K., Galvao, R. W., Dovidio, J. F., Willie, T. C., Safon, C. B., Kaplan, C., Caldwell, A., Blackstock, O., Phillips, N. J., & Kershaw, T. S. (2020). Contraception as a potential gateway to pre-exposure prophylaxis: US women’s pre-exposure prophylaxis modality preferences align with their birth control practices. AIDS Patient Care and STDs, 34(3), 132–146. https://doi.org/10.1089/apc.2019.0242
   PubMed Web of Science ®Google Scholar
• Calabrese, S. K., Krakower, D. S., & Mayer, K. H. (2017). Integrating HIV preexposure prophylaxis (PrEP) into routine preventive health care to avoid exacerbating disparities. American Journal of Public Health, 107(12), 1883–1889. https://doi.org/10.2105/AJPH.2017.304061
   PubMed Web of Science ®Google Scholar
• Calabrese, S. K., Krakower, D. S., Willie, T. C., Kershaw, T. S., & Mayer, K. H. (2019). US guideline criteria for human immunodeficiency virus preexposure prophylaxis: Clinical considerations and caveats. Clinical Infectious Diseases, 69(5), 884–889. https://doi.org/10.1093/cid/ciz046
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention, & US Public Health Service. (2018). Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 update: A clinical practice guideline. https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf
   Google Scholar
• Coy, K. C., Hazen, R. J., Kirkham, H. S., Delpino, A., & Siegler, A. J. (2019). Persistence on HIV preexposure prophylaxis medication over a 2-year period among a national sample of 7148 PrEP users, United States, 2015 to 2017. Journal of the International AIDS Society, 22(Article), e25252. https://doi.org/10.1002/jia2.25252
   PubMedGoogle Scholar
• Elion, R. A., Kabiri, M., Mayer, K. H., Wohl, D. A., Cohen, J., Beaubrun, A. C., & Altice, F. L. (2019). Estimated impact of targeted pre-exposure prophylaxis: Strategies for men who have sex with men in the United States. International Journal of Environmental Research and Public Health, 16(9), 1592. https://dx.doi.org/10.3390/ijerph16091592
   Web of Science ®Google Scholar
• Furukawa, N. W., Smith, D. K., Gonzalez, C. J., Huang, Y. A., Hanna, D. B., Felsen, U. R., Zhu, W., Arnsten, J. H., & Patel, V. V. (2020). Evaluation of algorithms used for PrEP surveillance using a reference population from New York City, July 2016-June 2018. Public Health Reports, 135(2), 202–210. https://doi.org/10.1177/0033354920904085
   PubMed Web of Science ®Google Scholar
• Goldstein, R. H., Streed, C. G., & Cahill, S. R. (2018). Being PrEPared - Preexposure prophylaxis and HIV disparities. The New England Journal of Medicine, 379(14), 1293–1295. https://dx.doi.org/10.1056/NEJMp1804306
   PubMed Web of Science ®Google Scholar
• Golub, S. A., Fikslin, R. A., Starbuck, L., & Klein, A. (2019). High rates of PrEP eligibility but low rates of PrEP access among a national sample of transmasculine individuals. Journal of Acquired Immune Deficiency Syndromes, 82(1), e1–e7. PMID: 31232834; PMCID: PMC6692190. https://doi.org/10.1097/QAI.0000000000002116
   PubMed Web of Science ®Google Scholar
• Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapia, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., Montoya-Herrera, O., Fernandez, T., Veloso, V., Buchbinder, S. P., Chariyalertsak, S., Schechter, M., Bekker, L.-G., Mayer, K. H., Kallas, E. G., … Glidden, D. V. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. The New England Journal of Medicine, 363(27), 2587. https://doi.org/10.1056/NEJMoa1011205
   PubMed Web of Science ®Google Scholar
• Heidari, S., Babor, T. F., De Castro, P., Tort, S., & Curno, M. (2016). Sex and gender equity in research: Rationale for the SAGER guidelines and recommended use. Research Integrity and Peer Review, 1(1), 1–9. https://doi.org/10.1186/s41073-016-0007-6
   PubMedGoogle Scholar
• Huang, Y. A., Weiming, Z., Smith, D. K., Harris, N., & Hoover, K. W. (2018). HIV preexposure prophylaxis, by race and ethnicity - United States, 2014-2016. Morbidity & Mortality Weekly Report, 67(41), 1147–1150. https://doi.org/10.15585/mmwr.mm6741a3
   PubMed Web of Science ®Google Scholar
• IBM Corp. (2019). IBM SPSS statistics for windows, version 25.0. [ Computer software]. IBM Corp.
   Google Scholar
• Jenness, S. M., Maloney, K. M., Smith, D. K., Hoover, K. W., Goodreau, S. M., Rosenberg, E. S., Weiss, K. M., Liu, A. Y., Rao, D. W., & Sullivan, P. S. (2019). Addressing gaps in HIV preexposure prophylaxis care to reduce racial disparities in HIV incidence in the United States. American Journal of Epidemiology, 188(4), 743–752. https://doi.org/10.1093/aje/kwy230
   PubMed Web of Science ®Google Scholar
• Koss, C. A., Hosek, S. G., Bacchetti, P., Anderson, P. L., Liu, A. Y., Horng, H., Wilson, C. M., Kuncze, K., Louie, A., Saberi, P., Wilson, C. M., & Gandhi, M. (2018). Comparison of measures of adherence to human immunodeficiency virus preexposure prophylaxis among adolescent and young men who have sex with men in the United States. Clinical Infectious Diseases, 66(2), 213–219. https://dx.doi.org/10.1093/cid/cix755
   PubMed Web of Science ®Google Scholar
• Liu, A. Y., Vittinghoff, E., Von, Amico, F. P., Anderson, K. R., Lester, P. L., Andrew, R., Estes, E., Serrano, I., Brothers, P., Buchbinder, J., Hosek, S., Fuchs, J. D., & Fuchs, J. D. (2019). Randomized controlled trial of a mobile health intervention to promote retention and adherence to preexposure prophylaxis among young people at risk for human immunodeficiency virus: The EPIC study. Clinical Infectious Diseases, 68(12), 2010–2017. https://dx.doi.org/10.1093/cid/ciy810
   PubMed Web of Science ®Google Scholar
• Macapagal, K., Kraus, A., Korpak, A. K., Jozsa, K., & Moskowitz, D. A. (2020). PrEP awareness, uptake, barriers, and correlates among adolescents assigned male at birth who have sex with males in the U.S. Archives of Sexual Behavior, 49(1), 113–124. https://doi.org/10.1007/s10508-019-1429-2
   PubMed Web of Science ®Google Scholar
• Mayer, K. H., Agwu, A., & Malebranche, D. (2020). Barriers to the wider use of pre-exposure prophylaxis in the United States: A narrative review. Advances in Therapy, 37(5), 1778–1811. https://doi.org/10.1007/s12325-020-01295-0
   PubMed Web of Science ®Google Scholar
• Moseholm, E., Gilleece, Y., Collins, B., Kowalska, J. D., Vasylyev, M., Pérez Elía, M. J., Cairns, G., & Aebi-Popp, K. (2020). Achievements and gaps to provide pre-exposure prophylaxis (PrEP) for women across the European Region - Results from a European survey study. Journal of Virus Eradication, 7(Article), 100026. https://doi.org/10.1016/j.jve.2020.100026
   PubMedGoogle Scholar
• Myers, J. E., Edelstein, Z. R., Daskalakis, D. C., Gandhi, A. D., Misra, K., Rivera, A. V., Salcuni, P. M., Scanlin, K., Udeagu, -C.-C., & Braunstein, S. L. (2018). Preexposure prophylaxis monitoring in New York City: A public health approach. American Journal of Public Health, 108(S4), 251–257. https://doi.org/10.2105/AJPH.2018.304729
   Google Scholar
• National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention. HIV prevention pill not reaching most Americans who could benefit - especially people of color. Retrieved May 21, 2021, from https://www.cdc.gov/nchhstp/newsroom/2018/croi-2018-PrEP-press-release.html
   Google Scholar
• Neumann, M. S., Finlayson, T. J., Pitts, N. L., & Keatley, J. (2017). Comprehensive HIV prevention for transgender persons. American Journal of Public Health, 107(2), 207–212. https://doi.org/10.2105/AJPH.2016.303509
   PubMed Web of Science ®Google Scholar
• Pardee, D. J., Sarvet, A., Mayer, G., Mayer, K. H., Sarvet, A., Mayer, G., & Mayer, K. H. (2019). High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States. Journal of the International AIDS Society, 22(Article), e25391. https://doi.org/10.1002/jia2.25391
   PubMedGoogle Scholar
• Planned Parenthood League of Massachusetts (2020). Planned parenthood league of Massachusetts’ three-year strategic plan. https://www.plannedparenthood.org/uploads/filer_public/47/f6/47f62a2b-a673-4643-9448-f519eac2e9b2/pplm_stratigeic_plan_one_pager.pdf
   Google Scholar
• Pulshiper, C. A., Montoya, J. A., Plant, A., Curtis, P., Holloway, I. W., & Leibowitz, A. A. (2016). Addressing PrEP disparities among young gay and bisexual men in California. California HIV/AIDS Research Program. https://aplahealth.org/wp-content/uploads/2016/09/APLA_PrEP_FullReport_WEB.pdf
   Google Scholar
• Pyra, M., Rusie, L. K., Baker, K. K., Baker, A., Ridgway, J., & Schneider, J. (2020). Correlations of HIV preexposure prophylaxis indications and uptake, Chicago, Illinois, 2015-2018. American Journal of Public Health, 110(3), 370–377. https://doi.org/10.2105/AJPH.2019.305469
   PubMed Web of Science ®Google Scholar
• Ransome, Y., Bogart, L. M., Kawachi, I., Kaplan, A., Mayer, K. H., & Ojikutu, B. (2020). Area-level HIV risk and socioeconomic factors associated with willingness to use PrEP among black people in the U.S. South. Annals of Epidemiology, 42, 33–41. https://doi.org/10.1016/j.annepidem.2019.11.002
   PubMed Web of Science ®Google Scholar
• Restar, A. J., Kuhns, L., Reisner, S. L., Ogunbajo, A., Garofalo, R., & Mimiaga, M. J. (2018). Acceptability of antiretroviral pre-exposure prophylaxis from a cohort of sexually experienced young transgender women in two US cities. AIDS and Behavior, 22(11), 3649–3657. https://doi.org/10.1007/s10461-018-2127-0
   PubMed Web of Science ®Google Scholar
• Sevelius, J. M., Poteat, T., Luhur, W. E., Reisner, S. L., & Meyer, I. H. (2020). HIV testing and PrEP use in a national probability sample of sexually active transgender people in the United States. Journal of Acquired Immune Deficiency Syndromes, 84(5), 437–442. https://doi.org/10.1097/QAI.0000000000002403
   PubMed Web of Science ®Google Scholar
• Shover, C. L., Javanbakht, M., Shoptaw, S., Bolan, R. K., Lee, S.-J., Parsons, J. T., Rendina, J., & Gorbach, P. M. (2018). HIV preexposure prophylaxis initiation at a large community clinic: Differences between eligibility, awareness, and uptake. American Journal of Public Health, 108(10), 1408–1417. https://doi.org/10.2105/AJPH.2018.304623
   PubMed Web of Science ®Google Scholar
• Siegler, A. J., Mouhanna, F., Giler, R. M., Weiss, K., Pembleton, E., Guest, J., Jones, J., Castel, A., Yeung, H., Kramer, M., McCallister, S., & Sullivan, P. S. (2018). The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis–to-need ratio in the fourth quarter of 2017, United States. Annals of Epidemiology, 28(12), 841–849. https://doi.org/10.1016/j.annepidem.2018.06.005
   PubMed Web of Science ®Google Scholar
• Sullivan, P. S., Giler, R. M., Mouhanna, F., Pembleton, E. S., Guest, J. L., Jones, J., Castel, A. D., Yeung, H., Kramer, M., McCallister, S., & Siegler, A. J. (2018). Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017. Annals of Epidemiology, 28(12), 833–840. https://doi.org/10.1016/j.annepidem.2018.06.009
   PubMed Web of Science ®Google Scholar
• Tanner, M. R., Miele, P., Carter, W., Valentine, S. S., Dunville, R., Kapogiannis, B. G., & Smith, D. K. (2020). Preexposure prophylaxis for prevention of HIV acquisition among adolescents: Clinical considerations, 2020. MMWR Recommendations and Reports, 69(3), 1. https://doi.org/10.15585/mmwr.rr6903a1
   PubMed Web of Science ®Google Scholar
• Valencia, R., Wang, L. Y., Dunville, R., Sharma, A., Sanchez, T., & Rosenberg, E. (2018). Sexual risk behaviors in adolescent sexual minority males: A systematic review and meta-analysis. The Journal of Primary Prevention, 39(6), 619–645. https://doi.org/10.1007/s10935-018-0525-8
   PubMed Web of Science ®Google Scholar
• Whitfield, T., Parsons, J. T., & Rendina, H. J. (2020). Rates of pre-exposure prophylaxis use and discontinuation among a large U.S. national sample of sexual minority men and adolescents. Archives of Sexual Behavior, 49(1), 103–112. https://doi.org/10.1007/s10508-019-01602-z
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2018). WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection: Module 5: Monitoring and evaluation. World Health Organization. https://apps.who.int/iris/bitstream/handle/10665/279834/WHO-CDS-HIV-18.10-eng.pdf
   Google Scholar